Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
MALTOL
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
MALTOL
×
Maximum Phase:
3
First Approval:
None
UNII:
3A9RD92BS4
Molecule Type:
Small molecule
Molecular Formula:
C6H6O3
Molecular Weight:
126.11
AlogP:
0.65
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ENZASTAURIN HYDROCHLORIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ENZASTAURIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
KX7K68Z2UH
Molecule Type:
Small molecule
Molecular Formula:
C32H30ClN5O2
Molecular Weight:
552.08
AlogP:
4.93
PSA:
72.16
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CANDESARTAN
(3)
Small molecule
Type-1 angiotensin II receptor antagonist
Unknown
Approved
Unknown
CANDESARTAN
×
Maximum Phase:
3
First Approval:
None
UNII:
S8Q36MD2XX
Molecule Type:
Small molecule
Molecular Formula:
C24H20N6O3
Molecular Weight:
440.46
AlogP:
4.03
PSA:
118.81
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PALOVAROTENE
(3)
Small molecule
Retinoic acid receptor gamma agonist
Unknown
Investigational
Unknown
PALOVAROTENE
×
Maximum Phase:
3
First Approval:
None
UNII:
28K6I5M16G
Molecule Type:
Small molecule
Molecular Formula:
C27H30N2O2
Molecular Weight:
414.55
AlogP:
6.15
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TENOFOVIR
(3)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
Unknown
Approved
Unknown
TENOFOVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
99YXE507IL
Molecule Type:
Small molecule
Molecular Formula:
C9H14N5O4P
Molecular Weight:
287.22
AlogP:
-0.05
PSA:
136.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
EPLIVANSERIN
(3)
Small molecule
Serotonin 2a (5-HT2a) receptor antagonist
Unknown
Investigational
Unknown
EPLIVANSERIN
×
Maximum Phase:
3
First Approval:
None
UNII:
3CO94WO6DJ
Molecule Type:
Small molecule
Molecular Formula:
C19H21FN2O2
Molecular Weight:
328.39
AlogP:
3.53
PSA:
45.06
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CIMETROPIUM
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CIMETROPIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
1N3H74AYTK
Molecule Type:
Small molecule
Molecular Formula:
C21H28NO4+
Molecular Weight:
358.46
AlogP:
1.84
PSA:
59.06
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TENELIGLIPTIN
(3)
Small molecule
Dipeptidyl peptidase IV inhibitor
Unknown
Approved
Unknown
TENELIGLIPTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
28ZHI4CF9C
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6OS
Molecular Weight:
426.59
AlogP:
1.57
PSA:
56.64
HBD:
1.0
HBA:
#RotB:
4.0
Source:
REMIMAZOLAM TOSYLATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
REMIMAZOLAM TOSYLATE
×
Maximum Phase:
3
First Approval:
None
UNII:
9J7J08A8LT
Molecule Type:
Small molecule
Molecular Formula:
C28H27BrN4O5S
Molecular Weight:
611.52
AlogP:
4.18
PSA:
69.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TUNLAMETINIB
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TUNLAMETINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SILYBIN A
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
SILYBIN A
×
Maximum Phase:
3
First Approval:
None
UNII:
33X338MNE4
Molecule Type:
Small molecule
Molecular Formula:
C25H22O10
Molecular Weight:
482.44
AlogP:
2.36
PSA:
155.14
HBD:
5.0
HBA:
#RotB:
4.0
Source:
JOSAMYCIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
JOSAMYCIN
×
Maximum Phase:
3
First Approval:
None
UNII:
HV13HFS217
Molecule Type:
Small molecule
Molecular Formula:
C42H69NO15
Molecular Weight:
828.01
AlogP:
3.01
PSA:
206.05
HBD:
3.0
HBA:
#RotB:
12.0
Source:
ALANYL GLUTAMINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALANYL GLUTAMINE
×
Maximum Phase:
3
First Approval:
None
UNII:
U5JDO2770Z
Molecule Type:
Small molecule
Molecular Formula:
C8H15N3O4
Molecular Weight:
217.22
AlogP:
-1.83
PSA:
135.51
HBD:
4.0
HBA:
#RotB:
6.0
Source:
DIQUAFOSOL TETRASODIUM
(3)
Small molecule
Purinergic receptor P2Y1 agonist
Unknown
Investigational
Unknown
DIQUAFOSOL TETRASODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
X8T9SBH9LL
Molecule Type:
Small molecule
Molecular Formula:
C18H22N4Na4O23P4
Molecular Weight:
878.24
AlogP:
-4.19
PSA:
404.45
HBD:
10.0
HBA:
#RotB:
14.0
Source:
INTEPIRDINE
(3)
Small molecule
Serotonin 6 (5-HT6) receptor antagonist
Unknown
Investigational
Unknown
INTEPIRDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
2IOB2M82HY
Molecule Type:
Small molecule
Molecular Formula:
C19H19N3O2S
Molecular Weight:
353.45
AlogP:
2.48
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SATRAPLATIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
SATRAPLATIN
×
Maximum Phase:
3
First Approval:
None
UNII:
8D7B37T28G
Molecule Type:
Small molecule
Molecular Formula:
C10H22Cl2N2O4Pt
Molecular Weight:
500.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RO-0622
(3)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
RO-0622
×
Maximum Phase:
3
First Approval:
None
UNII:
IJ2XP0ID0K
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIXALOMER
(3)
Small molecule
Phosphate sequestering agent
Unknown
Investigational
Unknown
BIXALOMER
×
Maximum Phase:
3
First Approval:
None
UNII:
3160WY51LV
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SORBINIL
(3)
Small molecule
Aldose reductase inhibitor
Unknown
Investigational
Unknown
SORBINIL
×
Maximum Phase:
3
First Approval:
None
UNII:
G4186B906P
Molecule Type:
Small molecule
Molecular Formula:
C11H9FN2O3
Molecular Weight:
236.2
AlogP:
0.64
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
0.0
Source:
CORTICOSTERONE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CORTICOSTERONE
×
Maximum Phase:
3
First Approval:
None
UNII:
W980KJ009P
Molecule Type:
Small molecule
Molecular Formula:
C21H30O4
Molecular Weight:
346.47
AlogP:
2.67
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
URAPIDIL
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
URAPIDIL
×
Maximum Phase:
3
First Approval:
None
UNII:
A78GF17HJS
Molecule Type:
Small molecule
Molecular Formula:
C20H29N5O3
Molecular Weight:
387.48
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TEGOPRAZAN
(3)
Small molecule
Potassium-transporting ATPase blocker
Unknown
Investigational
Unknown
TEGOPRAZAN
×
Maximum Phase:
3
First Approval:
None
UNII:
W017G7IF4S
Molecule Type:
Small molecule
Molecular Formula:
C20H19F2N3O3
Molecular Weight:
387.39
AlogP:
3.75
PSA:
67.45
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ARZOXIFENE
(3)
Small molecule
Estrogen receptor modulator
Unknown
Approved
Unknown
ARZOXIFENE
×
Maximum Phase:
3
First Approval:
None
UNII:
E569WG6E60
Molecule Type:
Small molecule
Molecular Formula:
C28H29NO4S
Molecular Weight:
475.61
AlogP:
6.94
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ETHYLENEDIAMINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ETHYLENEDIAMINE
×
Maximum Phase:
3
First Approval:
None
UNII:
60V9STC53F
Molecule Type:
Small molecule
Molecular Formula:
C2H8N2
Molecular Weight:
60.1
AlogP:
-1.1
PSA:
52.04
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TINLAREBANT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TINLAREBANT
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIANHYDROGALACTITOL
(3)
Small molecule
DNA cross-linking agent
Unknown
Investigational
Unknown
DIANHYDROGALACTITOL
×
Maximum Phase:
3
First Approval:
None
UNII:
4S465RYF7M
Molecule Type:
Small molecule
Molecular Formula:
C6H10O4
Molecular Weight:
146.14
AlogP:
-1.49
PSA:
65.52
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TRELAGLIPTIN
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
TRELAGLIPTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Q836OWG55H
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O2
Molecular Weight:
357.39
AlogP:
0.53
PSA:
97.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PARDOPRUNOX
(3)
Small molecule
Dopamine receptors; D2 & D3 partial agonist
Unknown
Investigational
Unknown
PARDOPRUNOX
×
Maximum Phase:
3
First Approval:
None
UNII:
5R72CHP32S
Molecule Type:
Small molecule
Molecular Formula:
C12H15N3O2
Molecular Weight:
233.27
AlogP:
0.87
PSA:
52.48
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TECARFARIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TECARFARIN
×
Maximum Phase:
3
First Approval:
None
UNII:
WN1479YT50
Molecule Type:
Small molecule
Molecular Formula:
C21H14F6O5
Molecular Weight:
460.33
AlogP:
5.13
PSA:
76.74
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DERSIMELAGON
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
DERSIMELAGON
×
Maximum Phase:
3
First Approval:
None
UNII:
1CWH5SV4G2
Molecule Type:
Small molecule
Molecular Formula:
C36H45F4N3O5
Molecular Weight:
675.76
AlogP:
5.95
PSA:
82.55
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CAFFEIC ACID
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CAFFEIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
U2S3A33KVM
Molecule Type:
Small molecule
Molecular Formula:
C9H8O4
Molecular Weight:
180.16
AlogP:
1.2
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
2.0
Source:
VOGLIBOSE
(3)
Small molecule
Alpha glucosidase inhibitor
Unknown
Approved
Unknown
VOGLIBOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
S77P977AG8
Molecule Type:
Small molecule
Molecular Formula:
C10H21NO7
Molecular Weight:
267.28
AlogP:
-4.49
PSA:
153.64
HBD:
8.0
HBA:
#RotB:
5.0
Source:
VATALANIB
(3)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
Unknown
Investigational
Unknown
VATALANIB
×
Maximum Phase:
3
First Approval:
None
UNII:
5DX9U76296
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClN4
Molecular Weight:
346.82
AlogP:
5.01
PSA:
50.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALMOREXANT
(3)
Small molecule
Orexin receptor antagonist
Unknown
Investigational
Unknown
ALMOREXANT
×
Maximum Phase:
3
First Approval:
None
UNII:
9KCW39P2EI
Molecule Type:
Small molecule
Molecular Formula:
C29H31F3N2O3
Molecular Weight:
512.57
AlogP:
5.74
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ETIRINOTECAN PEGOL
(3)
Small molecule
DNA topoisomerase I inhibitor
Unknown
Investigational
Unknown
ETIRINOTECAN PEGOL
×
Maximum Phase:
3
First Approval:
None
UNII:
LJ16641SFT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUADECITABINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
GUADECITABINE
×
Maximum Phase:
3
First Approval:
None
UNII:
2KT4YN1DP7
Molecule Type:
Small molecule
Molecular Formula:
C18H24N9O10P
Molecular Weight:
557.42
AlogP:
-2.63
PSA:
278.07
HBD:
6.0
HBA:
#RotB:
8.0
Source:
1
2
…
184
185
186
187
188
189
190
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA